AZRX stock forecast
Our latest prediction for AzurRx BioPharma, Inc.'s stock price was made on the June 30, 2017 when the stock price was at 4.02$.
In the short term (2weeks), AZRX's stock price should underperform the market by -0.97%. During that period the price should oscillate between -9.85% and +11.02%.
In the medium term (3months), AZRX's stock price should underperform the market by -1.49%. During that period the price should oscillate between -21.77% and +28.10%.Get email alerts
About AzurRx BioPharma, Inc.
AzurRx BioPharma, Inc. engages in the research and development of non-systemic biologics for the treatment of patients with gastrointestinal disorders. It focuses on MS1819-SD, and B-Lactamase program products. The company was founded on January 30, 2014 and is headquartered in Brooklyn, NY.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -0.85$ per share.
The book value per share is 0.45$
Three months stock forecastJune 30, 2017
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|